FDA Inspection 843603 — Altaire Pharmaceuticals, Inc.

Altaire Pharmaceuticals, Inc. — FEI 1000119582

The FDA completed an inspection of Altaire Pharmaceuticals, Inc. on August 8, 2013 in Aquebogue, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 8, 2013
Fiscal Year
2013
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Aquebogue, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122721 CFR 211.67(c)Cleaning/maintenance records not kept
154021 CFR 211.125(a)Strict control not exercised over labeling issued
241921 CFR 211.198(a)Complaint Handling Procedure
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
360321 CFR 211.160(b)Scientifically sound laboratory controls